Albireo Pharma Inc. (ALBO)
NASDAQ: ALBO
· Real-Time Price · USD
44.15
0.00 (0.00%)
At close: Mar 02, 2023, 10:00 PM
Albireo Pharma Revenue Breakdown
| Period Ending | Dec 31, 2021 |
|---|---|
| License Revenue | 15M |
| License Revenue Growth | n/a |
| Royalty Revenue | 18.59M |
| Royalty Revenue Growth | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2021 |
|---|---|
| Europe Revenue | 1.7M |
| Europe Revenue Growth | n/a |
| United States Revenue | 5.3M |
| United States Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 20.56M | 21.6M | 16.86M | 19.74M | 17.61M | 16.94M | 15.27M | 14.16M | 11.66M | 8.47M | 8.15M | 6.17M | 6.01M | 5.49M | 5.29M | 5.84M | 3.85M | 4.24M | 4.13M | 4.61M | 3.71M | 3.71M | 3.21M | n/a | 1.63M | 3.04M | 3.99M | 1.63M | 1.43M | 1.52M | 1.61M |
| Selling, General, and Administrative Revenue Growth | -4.80% | +28.15% | -14.63% | +12.11% | +3.97% | +10.91% | +7.88% | +21.39% | +37.63% | +3.94% | +32.03% | +2.75% | +9.57% | +3.63% | -9.44% | +51.82% | -9.16% | +2.66% | -10.49% | +24.35% | -0.11% | +15.60% | n/a | -100.00% | -46.25% | -23.89% | +144.42% | +13.89% | -6.03% | -5.34% | n/a |
| Research and Development Revenue | 23.31M | 22.89M | 21.9M | 20.6M | 21.08M | 20.89M | 19.94M | 20.05M | 22.2M | 18.4M | 16.13M | 14.22M | 12M | 11.03M | 8.33M | 9.5M | 9.67M | 6.41M | 6.15M | 3.99M | 3.23M | 2.96M | 2.81M | n/a | -67K | 64K | 2.09M | 1.59M | 1.99M | 5.05M | 2.92M |
| Research and Development Revenue Growth | +1.85% | +4.50% | +6.31% | -2.28% | +0.90% | +4.77% | -0.53% | -9.68% | +20.67% | +14.05% | +13.46% | +18.51% | +8.72% | +32.48% | -12.36% | -1.68% | +50.77% | +4.23% | +54.12% | +23.71% | +8.91% | +5.33% | n/a | -100.00% | -204.69% | -96.94% | +31.18% | -19.78% | -60.68% | +73.26% | n/a |